High SVR rates in patients with and without cirrhosis treated in real life with Sofosbuvir/Velpatasvir (SOF/VEL) combination for 12 weeks without Ribavirin (RBV)
Authors:
- A. MangiaA. Mangia
- R. LosappioRLR. Losappio
- M. MazzolaMMM. Mazzola
- E. VisaggiEVE. Visaggi
- D. BaccaDBD. Bacca
- F. SogariFSF. Sogari
- D. PotenzaDPD. Potenza
- I. CarraturoICI. Carraturo
- V. TagarielliVTV. Tagarielli
- 1 April 2018
- journal article
- conference paper
- Published by Elsevier in Journal of Hepatology
- Vol. 68, S273-S274